CELTAXSYS
Celtaxsys, is a biopharmaceutical company, engages in developing and testing drug compounds for treating cancer, and inflammatory and autoimmune diseases. Its technology manipulates immune cell migration as a treatment for cancer, inflammation, and organ/tissue rejection. The company's drug compounds are designed to block the protective mechanisms created by certain tumors to prevent attack by immune system cells.
CELTAXSYS
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2004-01-01
Address:
Atlanta, Georgia, United States
Country:
United States
Website Url:
http://www.celtaxsys.com
Total Employee:
11+
Status:
Closed
Contact:
(404) 920-0702
Email Addresses:
[email protected]
Total Funding:
65.16 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible GoDaddy DNS Google Google Cloud Pound Sterling OpenResty Japanese Yen Google Adsense Google Cloud Global Multi-Region
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Kamada
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Founder
Investors List
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation investment in Grant - Celtaxsys
Lumira Ventures
Lumira Ventures investment in Series E - Celtaxsys
RMI Partners
RMI Partners investment in Series E - Celtaxsys
Georgia Research Alliance
Georgia Research Alliance investment in Series E - Celtaxsys
Masters Capital Management
Masters Capital Management investment in Series E - Celtaxsys
Invus
Invus investment in Series E - Celtaxsys
Domain Associates
Domain Associates investment in Series E - Celtaxsys
GRA Venture Fund, LLC
GRA Venture Fund, LLC investment in Series D - Celtaxsys
Domain Associates
Domain Associates investment in Series D - Celtaxsys
Lumira Ventures
Lumira Ventures investment in Series D - Celtaxsys
Official Site Inspections
http://www.celtaxsys.com Semrush global rank: 4.37 M Semrush visits lastest month: 2.58 K
- Host name: 104.21.67.200
- IP address: 104.21.67.200
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
